Thinking of joining a study?

Register your interest

NCT04420702 | RECRUITING | Prostate Cancer


Diffusion Basis Spectrum Imaging of the Prostate
Sponsor:

Washington University School of Medicine

Brief Summary:

Diffusion Basis Spectrum Imaging (DBSI) represents a potential leap forward in improving prostate cancer early detection: a non-invasive and accurate imaging test for clinically significant prostate cancer.

Condition or disease

Prostate Cancer

Intervention/treatment

MRI with DBSI analysis

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 500 participants
Masking : SINGLE
Masking Description : -Dr. Kim will be blinded to the DBSI results at the time of biopsy, but will have the conventional MRI interpretation available
Primary Purpose : DIAGNOSTIC
Official Title : Diffusion Basis Spectrum Imaging of the Prostate: A Virtual Biopsy to Accurately Diagnose Prostate Cancer
Actual Study Start Date : 2020-02-27
Estimated Primary Completion Date : 2027-05-31
Estimated Study Completion Date : 2027-05-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: MALE
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Over 18 years of age and willing and able to provide informed consent.
  • * Patients with no prior diagnosis of prostate cancer, who are planning to undergo prostate biopsy as clinical standard of care ("early detection cohort")
  • * Including those men with
    • * an elevated PSA and no prior biopsy
    • * an elevated PSA and a negative prior biopsy
    • * Patients with a prior diagnosis of prostate cancer, who are currently managed with active surveillance, who are planning to undergo biopsy as clinical standard of care ("active surveillance cohort")
    Exclusion Criteria
    • * Patients with any clinical contraindication to MRI
    • \*Including but not limited to:
    • * Those with metallic implants, such as pacemakers or implantable cardioverter-defibrillators
    • * Those with cochlear implants
    • * Those with claustrophobia not relieved with medications (patients with claustrophobia who do not need medications for the scan or whose claustrophobia can be managed with medication, are eligible to participate)
    • * Those who cannot lie flat for over 1 hour
    • * Patients with prior prostate surgery for prostate cancer (e.g. radical prostatectomy, focal ablation)

Diffusion Basis Spectrum Imaging of the Prostate

Location Details

NCT04420702


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, Missouri

Washington University School of Medicine

St Louis, Missouri, United States, 63110

Loading...